All In Biotech

Drug Trial Radar · NCT06998043

Study With Phage for CF Subjects With Pseudomonas Lung Infection

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection

Last checked: Nov 19, 2026Latest source record: Jul 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

63

Planned (sponsor's estimate)

Start

Jul 2, 2025

Primary completion

Mar 2026

Study completion Sep 2026

Sponsor

Lead sponsor
BiomX LtdIndustry
Sponsor type
Industry
First posted
May 31, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects. The primary goal is to see if 8 weeks of twice daily BX004 can reduce the amount of PsA in the sputum compared to placebo (on top of background CF therapy).

Conditions

  • Chronic Pseudomonas Aeruginosa Infection
  • Cystic Fibrosis (CF)

Interventions

  • BX004Biological

    Bacteriophage

  • PlaceboOther

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in sputum Pseudomonas aeruginosa (PsA) burden at 8 weeks (EOT)Time frame: 8 weeks

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Providence Alaska Medical Center

    Anchorage, Alaska · Not yet recruiting

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas · Not yet recruiting

  • Stanford University

    Palo Alto, California · Not yet recruiting

  • University of California San Francisco

    San Francisco, California · Recruiting

  • National Jewish Health

    Denver, Colorado · Recruiting

  • Joe DiMaggio Children's Health

    Hollywood, Florida · Not yet recruiting

  • Central Florida Pulmonary Group

    Orlando, Florida · Recruiting

  • Avanza Medical Center

    Pensacola, Florida · Recruiting

  • Rutgers, Robert Wood Johnson Medical School

    New Brunswick, New Jersey · Recruiting

  • New York Medical College

    Hawthorne, New York · Recruiting

  • Northwell Health

    New York, New York · Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Recruiting

  • University of Utah

    Salt Lake City, Utah · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.